Cited by 69Schizophrenia research and treatmentTreatment of Major DepressionNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 281 of the 282 references it cites were found in a registry or an index.

The potential role of lamotrigine in schizophrenia

Large, Charles H., Webster, Elizabeth L., Goff, Donald C.·2005·Psychopharmacology

Open this paper in CoChat — free account

Abstract

Rationale Atypical antipsychotic drugs are the drugs of choice for the treatment of schizophrenia. However, despite advances, no treatments have been established for patients who fail to improve with the most effective of these, clozapine. The inhibition of dopamine transmission through blockade of dopamine D2 receptors is considered to be essential for antipsychotic efficacy, but it is postulated that modulation of glutamate transmission may be equally important. In support of this, symptoms similar to schizophrenia can be induced in healthy volunteers using N-methyl-D-aspartate (NMDA) antagonist drugs that are also known to enhance glutamate transmission. Furthermore, lamotrigine, which can modulate glutamate release, may add to or synergise with atypical antipsychotic drugs, some of which may themselves modulate glutamate transmission.Objectives We examine the evidence for the efficacy of lamotrigine. We consider how this fits with a glutamate neuron dysregulation hypothesis of the disorder. We discuss mechanisms by which lamotrigine might influence neuronal activity and glutamate transmission, and possible ways in which the drug might interact with antipsychotic medications.Results Data from four clinical studies support the efficacy of adjunctive lamotrigine in the treatment of schizophrenia. In addition, and consistent with a glutamate neuron dysregulation hypothesis of schizophrenia, lamotrigine can prevent the psychotic symptoms or behavioural disruption induced by NMDA receptor antagonists in healthy volunteers or rodents.Conclusions The efficacy of lamotrigine is most likely explained within the framework of a glutamate neuron dysregulation hypothesis, and may arise primarily through the drugs ability to influence glutamate transmission and neural activity in the cortex. The drug is likely to act through inhibition of voltage-gated sodium channels, though other molecular interactions cannot be ruled out. Lamotrigine may add to or synergise with some atypical antipsychotic drugs acting on glutamate transmission; alternatively, they may act independently on glutamate and dopamine systems to bring about a combined therapeutic effect. We propose new strategies for the treatment of schizophrenia using a combination of anti-dopaminergic and anti-glutamatergic drugs.

Integrity signals

Registry

Crossref · 10.1007/s00213-005-0020-9

Cites

281 of 281 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–281 of 281

The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice
Carlsson, M. L., Martin, P., Nilsson, M., Sorensen, S. M., Carlsson, A., Waters, N., & Waters, N. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050144 · Cited by 78
The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates
Dixon, J. F., & Hokin, L. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4757 · Cited by 77
Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia
Falke, E., Han, L.-Y., & Arnold, S. E. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00104-9 · Cited by 77
Effects of phencyclidine on immediate early gene expression in the brain
N�kki, R., Sharp, F. R., Sagar, S. M., & Honkaniemi, J. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960701)45:1 · Cited by 77
Brain stem auditory evoked potentials in unmedicated schizophrenic patients
Brecher, M., & Begleiter, H. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90082-4 · Cited by 74
Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocortical neurons in cell culture
Zona, C., & Avoli, M. (1990) · Experimental Brain Research · doi:10.1007/bf00228121 · Cited by 73
Modulation of Calcium and Potassium Currents by Lamotrigine
Grunze, H., von Wegerer, J., Greene, R. W., & Walden, J. (1998) · Neuropsychobiology · doi:10.1159/000026528 · Cited by 73
Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells.
Hough, C. J., Irwin, R. P., Gao, X., Rogawski, M. A., & Chuang, D. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12243-x · Cited by 72
M-100907 (Aventis).
de Paulis, T. (2001) · PubMed · Cited by 71
Therapeutic Implications of the Hyperglutamatergic Effects of NMDA Antagonists
Krystal, J. H. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00102-5 · Cited by 71
The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset
Smith, A. G., Neill, J. C., & Costall, B. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00230-5 · Cited by 71
Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine
Walker, M. C., Tong, X., Perry, H., Alavijeh, M. S., & Patsalos, P. N. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703337 · Cited by 71
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons
Calabresi, P., Centonze, D., Marfia, G. A., Pisani, A., & Bernardi, G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702361 · Cited by 71
Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics
Evins, A. E., Amico, E. T., Shih, V., & GOFF, D. C. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291892 · Cited by 70
Self-citation
Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents
Hainsworth, A. H., McNaughton, N. C. L., Pereverzev, A., Schneider, T., & Randall, A. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01625-x · Cited by 69
Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness
Breese, G. R., Knapp, D. J., & Moy, S. S. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00011-8 · Cited by 69
Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes
Lingamaneni, R., & Hemmings, H. C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00810-1 · Cited by 68
Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice
Brody, S. A., Geyer, M. A., & Large, C. H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1421-2 · Cited by 68
Self-citation
Which characteristics of schizophrenia predate psychosis?
Davies, N., Russell, A., Jones, P. B., & Murray, R. M. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00027-7 · Cited by 67
GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate
Motohashi, N. (1992) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(92)90062-j · Cited by 66
A calcium antagonistic effect of the new antiepileptic drug lamotrigine.
von Wegerer, J., Hesslinger, B., Berger, M., & Walden, J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00384-7 · Cited by 65
Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by acid
Morari, M., O'Connor, W. T., Ungerstedt, U., & Fuxé, K. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90611-4 · Cited by 64
Antiglutamatergic therapy in Alzheimer's disease - effects of lamotrigine
Tekin, S., Bingöl, C. A., Tanrıdağ, T., & Aktan, S. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050059 · Cited by 64
Phencyclidine and the midbrain dopamine system: Electrophysiology and behavior
French, E. D. (1994) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(94)90023-x · Cited by 61
Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis
Ueda, Y., & Willmore, L. J. (2000) · Experimental Brain Research · doi:10.1007/s002210000443 · Cited by 61
High 5HT 2A receptor occupancy in M100907-treated schizophrenic patients
Talvik, M., Nyberg, S., Nordström, A., Ito, H., Halldin, C., Brunner, F., & Farde, L. (2000) · Psychopharmacology · doi:10.1007/s002130050069 · Cited by 61
Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala: implications for its effects in seizure and affective disorders
Braga, M. F. M., Aroniadou‐Anderjaska, V., Post, R. M., & Li, H. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00198-8 · Cited by 61
The Glycine Site on the NMDA Receptor: Structure-Activity Relationships and Possible Therapeutic Applications
Dannhardt, G., & Kohl, B. K. (1998) · Current Medicinal Chemistry · doi:10.2174/0929867305666220314214937 · Cited by 61
Correlation between left frontal phospholipids and Wisconsin Card Sort Test performance in schizophrenia
Deicken, R. F. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00036-8 · Cited by 59
Neocortical Potassium Currents Are Enhanced by the Antiepileptic Drug Lamotrigine
Zona, C., Tancredi, V., Longone, P., D’Arcangelo, G., D’Antuono, M., Manfredi, M., & Avoli, M. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.51401.x · Cited by 59
N-Methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade
Heresco‐Levy, U. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001978 · Cited by 59
Attenuation of Ketamine Effects by Nimodipine Pretreatment in Recovering Ethanol Dependent Men Psychopharmacologic Implications of the Interaction of NMDA and L-Type Calcium Channel Antagonists
Krupitsky, E. M. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00346-3 · Cited by 58
Potassium currents in rat cortical neurons in culture are enhanced by the antiepileptic drug carbamazepine
Zona, C., Tancredi, V., Palma, E., Pirrone, G., & Avoli, M. (1990) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y90-079 · Cited by 57
Chronic administration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the rat
Tong, Z.-Y., Overton, P. G., & Clark, D. T. (1995) · Brain Research · doi:10.1016/0006-8993(94)01439-o · Cited by 56
Cortical gray matter volume deficits in schizophrenia: a replication
Lim, K. O., Sullivan, E. V., Zipursky, R. B., & Pfefferbaum, A. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00081-x · Cited by 56
Evidence that conditioned stress enhances outflow of dopamine in rat prefrontal cortex: A search for the influence of diazepam and 5-HT1A agonists
Wędzony, K., Maćkowiak, M., Fijał, K., & Gołembiowska, K. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199611)24:3 · Cited by 53
Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat
Halonen, T., Nissinen, J., & Pitkänen, A. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00278-9 · Cited by 51
Tardive dyskinesia and substrates of energy metabolism in CSF
GOFF, D. C., Tsai, G. E., Beal, M., & Coyle, J. T. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1730 · Cited by 51
Self-citation
Combined Treatment of Schizophrenic Psychoses with Haloperidol and Valproate
Dose, M., Hellweg, R., Yassouridis, A., Theison, M., & Emrich, H. M. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979312 · Cited by 49
Management of Treatment Resistant Schizophrenia Unresponsive to Clozapine
Barnes, T. R. E., McEvedy, C., & Nelson, H. E. (1996) · The British Journal of Psychiatry · doi:10.1192/s0007125000298590 · Cited by 47
Elevated Clozapine Plasma Level With Lamotrigine
KOSSEN, M., Selten, J.-P., & Kahn, R. S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1930 · Cited by 45
Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5‐hydroxytryptamine and dopamine in the hippocampus of the freely moving rat
Ahmad, S., Fowler, L. J., & Whitton, P. S. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705737 · Cited by 44
Effects of valproate on early and late potassium currents of single neurons
Walden, J., Altrup, U., Reith, H. B., & Speckmann, E. ‐. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90265-n · Cited by 42
Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats
Ahmad, S., Fowler, L. J., & Whitton, P. S. (2004) · Brain Research · doi:10.1016/j.brainres.2004.09.016 · Cited by 41
Interaction between carbamazepine, zonisamide and voltage-sensitive Ca2+ channel on acetylcholine release in rat frontal cortex
Zhu, G., Okada, M., Murakami, T., 河田, 祐., 鎌田, 晃., & Kaneko, S. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00015-3 · Cited by 41
Chronic lamotrigine treatment increases rat hippocampal GABA shunt activity and elevates cerebral taurine levels
Hassel, B., Taubøll, E., & Gjerstad, L. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(00)00196-0 · Cited by 41
Inhibitory Effect of Lamotrigine on A‐type Potassium Current in Hippocampal Neuron–Derived H19‐7 Cells
Huang, C., Huang, C., Liu, Y., & Wu, S. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.58403.x · Cited by 40
Dendritic Glutamate-Induced Bursting in the Prefrontal Cortex: Further Characterization and Effects of Phencyclidine
Shi, W., & Zhang, X.-X. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046359 · Cited by 37
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices
Calabresi, P., Siniscalchi, A., Pisani, A., Stefani, A., Mercuri, N. B., & Bernardi, G. (1996) · Neurology · doi:10.1212/wnl.47.2.557 · Cited by 36
Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex
Gronier, B., & Rasmussen, K. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00851-6 · Cited by 34
Valproate and neuroprotection
Vajda, F. J. E. (2002) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2002.1133 · Cited by 34
Relationship between plasma and brain levels and the anticonvulsant effect of lamotrigine in rats
Castel‐Branco, M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.09.065 · Cited by 34
Augmentation of haloperidol by ascorbic acid in phencyclidine intoxication
Giannini, A. J., Loiselle, R. H., Dimarzio, L. R., & Giannini, M. C. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.9.1207 · Cited by 34
Lamotrigine trial in idiopathic parkinsonism
Shinotoh, H., Vingerhoets, F. J. G., Lee, C. S., Uitti, R. J., Schulzer, M., Calne, D. B., & Tsui, J. K. C. (1997) · Neurology · doi:10.1212/wnl.48.5.1282 · Cited by 33
Carbamazepine Maintenance Treatment in Outpatient Schizophrenics
Carpenter, W. T. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250071010 · Cited by 33
Neuroprotective Effects of a Dual L/N-type Ca2+ Channel Blocker Cilnidipine in the Rat Focal Brain Ischemia Model
Takahara, A., Konda, T., Enomoto, A., & Kondo, N. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1388 · Cited by 32
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature
Vita, A., Dieci, M., Giobbio, G. M., Tenconi, F., & INVERNIZZI, G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00085-0 · Cited by 32
Influence of r-type (Cav2.3) and t-type (Cav3.1–3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis
Bergquist, F., & Nissbrandt, H. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00385-3 · Cited by 32
Modulation of the ability of clozapine to facilitate NMDA‐ and electrically evoked responses in pyramidal cells of the rat medial prefrontal cortex by dopamine: pharmacological evidence
Ninan, I., & Wang, R. Y. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02549.x · Cited by 32
State-dependent regulation of neuronal excitability by dopamine.
Surmeier, D. J., & Kitai, S. T. (1997) · PubMed · Cited by 31
A clinical trial of nifedipine in schizophrenia and tardive dyskinesia
Suddath, R. L., Straw, G., Freed, W. J., Bigelow, L. B., Kirch, D. G., & Wyatt, R. J. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90157-w · Cited by 30
The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis
Carter, K., Dickerson, J., Schoepp, D. D., Reilly, M., Herring, N. R., Williams, J. M., Sallee, F. R., Sharp, J. W., & Sharp, F. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.018 · Cited by 29
Effect of valproic acid on behavior and plasma amino acid concentrations in chronic schizophrenic patients
Ko, G. N., Korpi, E. R., Freed, W. J., Zalcman, S. J., & Bigelow, L. B. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90085-x · Cited by 28
Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats
Schwabe, K., Brosda, J., Wegener, N., & Koch, M. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.11.008 · Cited by 28
M100907, a selective 5-HT2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain
Habara, T., Hamamura, T., Miki, M., Ohashi, K., & Kuroda, S. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00926-8 · Cited by 27
Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients.
STEDMAN, T. J., Whiteford, H., Eyles, D. W., Welham, J., & Pond, S. M. (1991) · PubMed · Cited by 25
Neuropathological studies of brain tissue in schizophrenia
Bunney, B. G., Potkin, S. G., & Bunney, W. E. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00038-6 · Cited by 24
Effects of Nifedipine on Psychosis and
STEDMAN, T. J., Franzcp, Whiteford, H., Eyles, D. W., Welham, J., & Pond, S. M. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199102000-00006 · Cited by 24
Neuroprotective effects of lamotrigine enhanced by flunarizine in gerbil global ischemia
Lee, Y.-S., Yoon, B., & Roh, J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00225-6 · Cited by 22
Lamotrigine in Parkinson's disease — a double blind study
Zipp, F., Bürklin, F., Stecker, K., Baas, H. K. J., & Fischer, P.-A. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251231 · Cited by 22
Valproate for schizophrenia
Basan, A., & Leucht, S. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004028.pub2 · Cited by 22
Effects of Carbamazepine and Novel 10,11‐Dihydro‐5H‐Dibenz[b,f]Azepine‐5‐Carboxamide Derivatives on Synaptic Transmission in Rat Hippocampal Slices
Cunha, R. A., Coelho, J. E., Costenla, A. R., Lopes, L. V., Parada, A., de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900407.x · Cited by 20
Selective attention and response strategies as factors in serial reversal learning.
Mackintosh, N. J., & Little, L. (1969) · Canadian Journal of Psychology/Revue Canadienne de Psychologie · doi:10.1037/h0082821 · Cited by 19
Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-activated (HVA) calcium channels in dissociated neurones of rat cortex
Hainsworth, A. H., Spadoni, F., Lavaroni, F., Bernardi, G., & Stefani, A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00004-1 · Cited by 18
The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents
Parepally, H., Chakravorty, S., Levine, J., Brar, J. S., Patel, A. M., Baird, J. W., Chalasani, L., Delaney, J., Atzert, R., & Chengappa, K. N. R. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00279-2 · Cited by 18
Nilvadipine Is Effective for Chronic Schizophrenia in a Double-Blind Placebo-Controlled Study
Yamada, K., Kanba, S., Ashikari, I., Ohnishi, K., Yagi, G., & Asai, M. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199612000-00005 · Cited by 17
In vivo effects of anticonvulsant drugs on nerve terminal (synaptosomal) GABA levels in 11 brain regions of the rat
L�scher, W., Vetter, M., B�hme, G., & Stoltenburg, G. (1985) · Journal of Neural Transmission · doi:10.1007/bf01252615 · Cited by 14
Effects of Lamotrigine on Field Potentials and Long‐Term Potentiation in Guinea Pig Hippocampal Slices
Langosch, J. M., Zhou, X., Frick, A., Grunze, H., & Walden, J. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00314.x · Cited by 13
Associative somatodendritic interaction in layer V pyramidal neurons is not affected by the antiepileptic drug lamotrigine
Berger, T. K., & Lüscher, H. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03617.x · Cited by 13
Loss of Spines and Neuropil
Jones, L. B. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59001-3 · Cited by 5
Progressive Brain Volume Changes and the Clinical Course of Schizophrenia in Men: A Longitudinal Magnetic Resonance Imaging Study
Mathalon, D. H., Sullivan, E. V., Lim, K. O., & Pfefferbaum, A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.148

Flagged first, then by citations

1 of the 282 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Bakshi VP, Geyer MA (1997) Reversal of phencyclidine-induced deficits in prepulse inhibition by prazosin, an alpha-1 adrenergic antagonist. J Pharmacol Exp Ther 283:666–674
Idris NF, Repeto P, Neill JC, Large CH (2005) Investigation of the effects of lamotrigine and clozapine to improve reversal learning impairments induced by acute PCP and d-amphetamine in the rat. Psychopharmacology. Epub ahead of print · DOI
Karper LP, Grillon C, Morrissey K, Abi-Saab D, Morgan CA, Charney DS, Krystal JH (1994) The effect of ketamine on the acoustic startle response. Soc Neurosci Abstr 20:482

Sorted by citations

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Barnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 615
Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
Barnes, T. R. E. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 369
Glutamate and the Neural Basis of the Subjective Effects of Ketamine: A Pharmaco–Magnetic Resonance Imaging Study
Deakin, J. F. W., Lees, J., McKie, S., Hallak, J. E. C., Williams, S. R., & Dursun, S. M. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.37 · Cited by 311
Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model
Murray, J. D., Anticevic, A., Gancsos, M., Ichinose, M., Corlett, P. R., Krystal, J. H., & Wang, X.-J. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs370 · Cited by 255

See all 69

Authors: Large, C. H., Webster, E. L., & Goff, D. C.
Affiliations: GlaxoSmithKline (Italy) (IT)
GlaxoSmithKline (United States) (US)
Massachusetts General Hospital (US)
Corresponding author: Large, Charles H.
ORCID: Large, Charles H.
Webster, Elizabeth L.
Goff, Donald C.
Venue: Psychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2005-07-06
Volume: 181
Issue: 3
Pages: 415-436
ISSN: 0033-3158 (ISSN-L)
1432-2072
DOI: 10.1007/s00213-005-0020-9
OpenAlex: W2039572620
Cited by: 69
References: 282
Citations by year: 2025: 1 · 2024: 1 · 2023: 4 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 1 · 2013: 2 · 2012: 4
FWCI: 1.09
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: lamotrigine, schizophrenia, glutamatergic neurotransmission, NMDA receptor antagonists, atypical antipsychotics, adjunctive therapy, dopamine D2 receptor, voltage-gated sodium channels, drug synergy
MeSH terms: Lamotrigine, Animals, Anticonvulsants, Brain, Disease Models, Animal, Drug Synergism, Drug Therapy, Combination, Humans, Schizophrenia, Schizophrenic Psychology, Antipsychotic Agents, Triazines, Glutamic Acid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The potential role of lamotrigine in schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks